NASDAQ:PAVM
PAVmed Inc Stock News
$2.25
+0.0500 (+2.27%)
At Close: May 09, 2024
Fly Intel: After-Hours Movers PAVM;BCRX;HA;I;WDFC;AERI;BOOT
12:09pm, Thursday, 09'th Apr 2020
Fly Intel: After-Hours Movers PAVM BCRX HA I WDFC AERI BOOT
The Week Ahead In Biotech: Spotlight On Q1 Pre-Announcements As COVID-19 Continues To Disrupt Operations
06:03pm, Sunday, 05'th Apr 2020
Biotech stocks went along with the broader market flow in the week ended April 3, with the COVID-19 pandemic dictating sentiment. The week witnessed a host of clinical readouts...
PAVmed Subsidiary Lucid Diagnostics’ EsoCheck Esophageal Cell Collection Device Receives Prestigious Edison Best New Product Award
01:30pm, Thursday, 02'nd Apr 2020
PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multiproduct medical device company, today announced that the EsoCheck™ Esophageal Cell Collection Dev
PAVmed Receives $6.3 Million in Gross Proceeds from Completion of November 2019 Financing
01:30pm, Tuesday, 31'st Mar 2020
PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multiproduct medical device company, today announced it has received $6.3 million in new gross proceeds
PAVmed to Hold Business Update Conference Call on April 9, 2020
01:30pm, Tuesday, 24'th Mar 2020
NEW YORK, March 24, 2020 -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multiproduct medical device company, today announced that.
PAVmed Announces FDA 510(k) Re-submission for its CarpX™ Minimally Invasive Carpal Tunnel Device
01:30pm, Monday, 09'th Mar 2020
PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multiproduct medical device company, today announced the U.S. Food and Drug Administration (FDA) has ack
PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multiproduct medical device company, today announced that its majority owned subsidiary, Lucid Diagnosti
W, VMW among premarket losers
02:17pm, Friday, 28'th Feb 2020
Big Lots (NYSE:BIG) -35% on Q4 earnings.Tonix Pharmaceuticals (NASDAQ:TNXP) -23% after pricing stock offering.Celsion (NASDAQ:CLSN) -19% after pricing registered direct offering.Wayfair (NY
ABEV, PLAN among premarket losers
02:17pm, Thursday, 27'th Feb 2020
Anaplan (NYSE:PLAN) -29% despite Q4 beat.Continental Resources (NYSE:CLR) -26% on Q4 earnings.Nutanix (NASDAQ:NTNX) -20% on Q2 earnings.Virgin Galactic Holdings (NYSE:SPCE) -18% after pair of
PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multiproduct medical device company, today announced that its majority owned subsidiary, Lucid Diagnosti
The Daily Biotech Pulse: FDA Snub For Merck, Priority Review For Roche's Tecentriq sBLA
12:21pm, Wednesday, 19'th Feb 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 18) Adverum Biotechnologies Inc (NASDAQ: ADVM ) Anavex
PAVmed Adds EsoCure™ Esophageal Ablation Device with Patented Caldus™ Technology to Commercial Product Pipeline
02:30pm, Tuesday, 18'th Feb 2020
PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multiproduct medical device company, today announced it has added the EsoCure™ Esophageal Ablation Dev
The Daily Biotech Pulse: J&J Intensifies Efforts On COVID-19 Cure, Adamas Reports Positive, Long-Term Gocovri Data
02:18pm, Wednesday, 12'th Feb 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 11) AbbVie Inc (NYSE: ABBV ) Acceleron Pharma Inc (NAS
U.S. FDA Grants PAVmed Subsidiary, Lucid Diagnostics, Breakthrough Device Designation for its EsoGuard Esophageal DNA Test
02:30pm, Tuesday, 11'th Feb 2020
PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multiproduct medical device company, today announced that the Company’s majority owned subsidiary, Luc
The following is a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs on Jan. 13.) Arvinas Inc (NASDAQ: ARVN ) Baxter Int
